These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18216387)

  • 21. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose effect of fenfluramine-phentermine in the production of valvular heart disease.
    Tovar EA; Landa DW; Borsari BE
    Ann Thorac Surg; 1999 Apr; 67(4):1213-4. PubMed ID: 10320298
    [No Abstract]   [Full Text] [Related]  

  • 23. Heart valve disorders and appetite-suppressant drugs.
    Jick H
    JAMA; 2000 Apr; 283(13):1738-40. PubMed ID: 10755501
    [No Abstract]   [Full Text] [Related]  

  • 24. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease.
    Boughner DR
    CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558
    [No Abstract]   [Full Text] [Related]  

  • 25. Selections from current literature: pharmacological treatment of obesity.
    Connolly J; Verni C; Trilling J; Kelso E; Shiesha S
    Fam Pract; 1998 Feb; 15(1):88-93. PubMed ID: 9527304
    [No Abstract]   [Full Text] [Related]  

  • 26. Valve disease due to appetite suppressants (cont'd).
    Prescrire Int; 1999 Aug; 8(42):115. PubMed ID: 11503830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anorectic-induced valvulopathy.
    Cheng TO
    Eur Heart J; 2000 Apr; 21(7):593-4. PubMed ID: 10775015
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anorectic drugs and valvular heart disease.
    Cheng TO
    Cleve Clin J Med; 1998 May; 65(5):277; author reply 277-8. PubMed ID: 9599913
    [No Abstract]   [Full Text] [Related]  

  • 31. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.
    Lepor NE; Gross SB; Daley WL; Samuels BA; Rizzo MJ; Luko SP; Hickey A; Buchbinder NA; Naqvi TZ
    Am J Cardiol; 2000 Jul; 86(1):107-10. PubMed ID: 10867106
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity and the diet pill dilemma.
    Healy BP
    J Womens Health; 1997 Aug; 6(4):391-2. PubMed ID: 9279828
    [No Abstract]   [Full Text] [Related]  

  • 34. Fen-phen and risk of valvular disease.
    SoRelle R
    Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046
    [No Abstract]   [Full Text] [Related]  

  • 35. US journal finds lower risk from diet pills.
    Josefson D
    BMJ; 1997 Nov; 315(7119):1329. PubMed ID: 9402766
    [No Abstract]   [Full Text] [Related]  

  • 36. Phen-fen fallout. Financial side effects.
    Sandrick KM
    Hosp Health Netw; 1998 Feb; 72(4):90. PubMed ID: 9553524
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
    JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL
    JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual hypotension and bradycardia in a patient receiving fenfluramine, phentermine, and fluoxetine.
    Rich JM; Njo L; Roberts KW; Smith KP
    Anesthesiology; 1998 Feb; 88(2):529-31. PubMed ID: 9477076
    [No Abstract]   [Full Text] [Related]  

  • 40. Report links appetite suppressants with heart disease. FDA encourages reporting of like events.
    Am J Health Syst Pharm; 1997 Aug; 54(16):1785, 1788. PubMed ID: 9269513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.